Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: A naturalistic treatment pilot PET study

Synapse

Volumn 67, Issue 11, 2013, Pages 773-778

  Lan, Martin J ^a,b   Hesselgrave, Natalie ^b   Ciarleglio, Adam ^b,c   Ogden, R Todd ^b,c   Sullivan, Gregory M ^a,b   Mann, J John ^a,b   Parsey, Ramin V ^d  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Columbia University School of Public Health ^*  (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

11C WAY 100635; Antidepressant; Bipolar disorder; Mood stabilizer; PET

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBON 11; MOOD STABILIZER; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; BINDING AFFINITY; BIPOLAR DEPRESSION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DSM-IV; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL PATIENT; METABOLITE; NEUROIMAGING; OUTPATIENT CARE; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIDEPRESSANT; BIPOLAR DISORDER; MOOD STABILIZER; PET; [11C]WAY-100635;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; REMISSION INDUCTION; SEROTONIN; SEROTONIN 5-HT1 RECEPTOR AGONISTS; TREATMENT OUTCOME;

EID: 84884204384     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21684     Document Type: Article

References (31)

1. Baldessarini RJ, Vieta E, Calabrese JR, Tohen M, Bowden CL. 2010. Bipolar depression: Overview and commentary. Harv Rev Psychiatry 18:143-157.
2. Bauer M, Pfennig A. 2005. Epidemiology of bipolar disorders. Epilepsia 46(Suppl 4):8-13.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
4. Belmaker RH. 2004. Bipolar disorder. N Engl J Med 351:476-486.
5. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C. 1998. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 861:204-216.
6. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C. 1999. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-1387.
7. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C. 2007. Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nucl Med Biol 34:865-877.
8. Endicott J, Spitzer RL, Fleiss JL, Cohen J. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-771.
9. First M, Spitzer RL, Gibbon M, Williams JBW. 1994. Structured clinical interview for DSM-IV axis I disorders (SCID-I/P), Version 2.0, Patient ed. New York: Biometrics Research, New York State Psychiatric Institute.
10. Gray NA, Milak MS, Delorenzo C, Ogden RT, Huang YY, Mann JJ, Parsey RV. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biol Psychiatry (in press).
11. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
12. Harris EC, Barraclough B. 1997. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 170:205-228.
13. 1A receptor C(-1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 7:441-451.
14. Mickey BJ, Ducci F, Hodgkinson CA, Langenecker SA, Goldman D, Zubieta JK. 2008. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. J Neurosci 28:11354-11359.
15. Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN. 2001. Cerebral white matter lesions in bipolar affective disorder: Relationship to outcome. Br J Psychiatry 178:172-176.
16. Ogden RT, Tarpey T. 2006. Estimation in regression models with externally estimated parameters. Biostatistics 7:115-129.
17. 1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: Comparison of arterial and reference tisssue input functions. J Cereb Blood Flow Metab 20:1111-1133.
18. 1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954:173-182.
19. 1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab 25:785-793.
20. 1A receptor binding potential during a major depressive episode predicts poor treatment response: Preliminary data from a naturalistic study. Neuropsychopharmacology 31:1745-1749.
21. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ. 2006b. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59:106-113.
22. Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E, Mikhno A, Milak M, Zanderigo F, Sullivan GM, Oquendo MA, Mann JJ. 2010. Higher serotonin 1A binding in a second major depression cohort: Modeling and reference region considerations. Biol Psychiatry 68:170-178.
23. Regenold WT, Hisley KC, Phatak P, Marano CM, Obuchowski A, Lefkowitz DM, Sassan A, Ohri S, Phillips TL, Dosanjh N, Conley RR, Gullapalli R. 2008. Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients. Bipolar Disord 10:753-764.
24. Salvi V, Fagiolini A, Swartz HA, Maina G, Frank E. 2008. The use of antidepressants in bipolar disorder. J Clin Psychiatry 69:1307-1318.
25. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-180.
26. Shrestha S, Hirvonen J, Hines CS, Henter I, Svenningsson P, Pike VW, Innis RB. 2012. Serotonin-1A receptors in major depression quantified using PET: Controversies, confounds, and recommendations. Neuroimage 59:3243-3251.
27. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV. 2009. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 66:223-230.
28. The World Health Report. 2002. Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization.
29. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK. 1996. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293-299.
30. 1A receptor gene. Psychiatr Genet 9:105-106.
31. Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435.